Ultragenyx Pharmaceutical Inc.

Other

US·SEC (Form 4)

Arcturus Therapeutics Holdings Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€69m

▼ Sales (2 ops.)

Explore the complete record of transactions filed by Ultragenyx Pharmaceutical Inc.. Officer active across 1 companies, notably Arcturus Therapeutics Holdings Inc.. Cumulatively, 2 disclosures have been published. Total volume traded: €68.6m. The latest transaction was filed on 10 August 2021 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.

Declarations2 total

Executives▼SaleAArcturus Therapeutics Holdings Inc.29SEC

U

Ultragenyx Pharmaceutical Inc.Director

€34m725,000 shares@ €47.2903100.0% of flow

Common Stock

SEC:0001209191-21-051182·10 Aug 2021

SEC ↗

Executives▼SaleAArcturus Therapeutics Holdings Inc.◆Signal · 47SEC

U

Ultragenyx Pharmaceutical Inc.Director

€34m725,000 shares@ €47.290319.69% mcap50.0% of flow